TRAM1 Promotes Microglia M1 Polarization

Journal of Molecular Neuroscience

Volumn 58, Issue 2, 2016, Pages 287-296

  Wang, Hanxiang ^a   Liu, Chun ^a   Han, Ming ^a   Cheng, Chun ^a   Zhang, Dongmei ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

INOS; LPS IFN ; Microglia M1 polarization; TBK; TRAM1

Indexed keywords

GAMMA INTERFERON; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; TRANSCRIPTION FACTOR RELA; TRANSLOCATION ASSOCIATED MEMBRANE PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARRIER PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN DERIVATIVE; IRAK1 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TRAM1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL POLARIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GENETIC TRANSFECTION; MICROGLIA; MOUSE; NEWBORN; NONHUMAN; POLARIZATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; GENETICS; METABOLISM;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; INTERFERON-GAMMA; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKINS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICROGLIA; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; TOLL-LIKE RECEPTOR 4;

EID: 84958053445     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-015-0678-3     Document Type: Article

References (37)

1. Ajmone-Cat MA, Mancini M, et al. (2013) Microglial polarization and plasticity: evidence from organotypic hippocampal slice cultures. Glia 61(10):1698–1711
2. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4(7):499–511
3. Chhor V, Le Charpentier T, et al. (2013) Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun 32:70–85
4. Colton C, Wilcock DM (2010) Assessing activation states in microglia. CNS Neurol Disord Drug Targets 9(2):174–191
5. Colton CA, Mott RT, et al. (2006) Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 3:27
6. Crain JM, Nikodemova M, et al. (2013) Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. J Neurosci Res 91(9):1143–1151
7. David S, Kroner A (2011) Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12(7):388–399
8. Ellert-Miklaszewska A, Dabrowski M, et al. (2013) Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia. Glia 61(7):1178–1190
9. Ghosh M, Subramani J, et al. (2015) CD13 restricts TLR4 endocytic signal transduction in inflammation. J Immunol 194(9):4466–4476
10. Gwack Y, Srikanth S, et al. (2007) Biochemical and functional characterization of orai proteins. J Biol Chem 282(22):16232–16243
11. Hanisch UK, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10(11):1387–1394
12. Hirotani T, Yamamoto M, et al. (2005) Regulation of lipopolysaccharide-inducible genes by MyD88 and toll/IL-1 domain containing adaptor inducing IFN-beta. Biochem Biophys Res Commun 328(2):383–392
13. Hu X, Li P, et al. (2012) Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43(11):3063–3070
14. Kagan JC, Medzhitov R (2006) Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling. Cell 125(5):943–955
15. Kagan JC, Su T, et al. (2008) TRAM couples endocytosis of toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9(4):361–368
16. Kim M, Choi SY, et al. (2015) Neochlorogenic acid inhibits lipopolysaccharide-induced activation and pro-inflammatory responses in BV2 microglial cells. Neurochem Res 40(9):1792–1798
17. Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11(11):750–761
18. Liu B, Hong JS (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304(1):1–7
19. Mantovani A, Sozzani S, et al. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549–555
20. Martinez FO, Helming L, et al. (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451–483
21. Minghetti L, Levi G (1998) Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 54(1):99–125
22. Ng CL, Oresic K, et al. (2010) TRAM1 is involved in disposal of ER membrane degradation substrates. Exp Cell Res 316(13):2113–2122
23. Oshiumi H, Sasai M, et al. (2003) TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem 278(50):49751–49762
24. Plociennikowska A, Hromada-Judycka A, et al. (2015) Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 72(3):557–581
25. Ponomarev ED, Maresz K, et al. (2007) CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 27(40):10714–10721
26. Ponomarev ED, Veremeyko T, et al. (2011) MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat Med 17(1):64–70
27. Rivest S (2011) The promise of anti-inflammatory therapies for CNS injuries and diseases. Expert Rev Neurother 11(6):783–786
28. Rojo AI, Innamorato NG, et al. (2010) Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson’s disease. Glia 58(5):588–598
29. Rowe DC, McGettrick AF, et al. (2006) The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc Natl Acad Sci U S A 103(16):6299–6304
30. Shimizu E, Kawahara K, et al. (2008) IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1–42) by rat primary type 2 microglia. J Immunol 181(9):6503–6513
31. Smith PF (2008) Inflammation in Parkinson’s disease: an update. Curr Opin Investig Drugs 9(5):478–484
32. Tanaka T, Murakami K, et al. (2015) Interferon regulatory factor 7 participates in the M1-like microglial polarization switch. Glia 63(4):595–610
33. Tremblay ME, Stevens B, et al. (2011) The role of microglia in the healthy brain. J Neurosci 31(45):16064–16069
34. Verreck FA, de Boer T, et al. (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 101(13):4560–4565
35. Verstak B, Nagpal K, et al. (2009) MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. J Biol Chem 284(36):24192–24203
36. Wang X, Stridh L, et al. (2009) Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 183(11):7471–7477
37. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16(2):109–110